Effects of Specific Multi-Nutrient Enriched Diets on Cerebral Metabolism, Cognition and Neuropathology in AβPPswe-PS1dE9 Mice

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Jansen, Diane ^a   Zerbi, Valerio ^a   Arnoldussen, Ilse A C ^a   Wiesmann, Maximilian ^a   Rijpma, Anne ^a   Fang, Xiaotian T ^a   Dederen, Pieter J ^a   Mutsaers, Martina P C ^a   Broersen, Laus M ^b   Lütjohann, Dieter ^c   Miller, Malgorzata ^a   Joosten, Leo A B ^a   Heerschap, Arend ^a   Kiliaan, Amanda J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b DANONE RESEARCH   (Netherlands)

^c UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; AMYLOID PRECURSOR PROTEIN; ASCORBIC ACID; CHOLESTEROL; CHOLINE; CYANOCOBALAMIN; DOCOSAHEXAENOIC ACID; FATTY ACID; FOLIC ACID; ICOSAPENTAENOIC ACID; INTERLEUKIN 1BETA; MESSENGER RNA; PHOSPHOLIPID; PRESENILIN 1; PYRIDOXINE; SELENIUM; URIDINE PHOSPHATE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; BRAIN METABOLISM; COGNITION; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; HIPPOCAMPUS; MALE; MOUSE; NERVE DEGENERATION; NERVE REGENERATION; NERVOUS SYSTEM DEVELOPMENT; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; THERAPY EFFECT;

ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; ANIMALS; BRAIN; CHOLESTEROL; COGNITION; DNA PRIMERS; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; FATTY ACIDS; FOOD, FORTIFIED; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-1BETA; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MAZE LEARNING; MICE; MICE, MUTANT STRAINS; REAL-TIME POLYMERASE CHAIN REACTION; URIDINE MONOPHOSPHATE;

EID: 84884569843     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0075393     Document Type: Article

References (172)

1. Wu L, Rosa-Neto P, Hsiung GY, Sadovnick AD, Masellis M, et al. (2012) Early-onset familial Alzheimer's disease (EOFAD). Can J Neurol Sci 39: 436-445.
2. Tanzi RE, Bertram L, (2001) New frontiers in Alzheimer's disease genetics. Neuron 32: 181-184.
3. Braak E, Griffing K, Arai K, Bohl J, Bratzke H, et al. (1999) Neuropathology of Alzheimer's disease: what is new since A. Alzheimer? Eur Arch Psychiatry Clin Neurosci 249Suppl 3: 14-22.
4. Mattson MP, (2004) Pathways towards and away from Alzheimer's disease. Nature 430: 631-639.
5. de la Torre JC, (2002) Vascular basis of Alzheimer's pathogenesis. Ann N Y Acad Sci 977: 196-215.
6. Iadecola C, (2004) Neurovascular regulation in the normal brain and in Alzheimer's disease. Nat Rev Neurosci 5: 347-360.
7. Skoog I, Gustafson D, (2006) Update on hypertension and Alzheimer's disease. Neurol Res 28: 605-611.
8. Whitmer RA, Gustafson DR, Barrett-Connor E, Haan MN, Gunderson EP, et al. (2008) Central obesity and increased risk of dementia more than three decades later. Neurology 71: 1057-1064.
9. Rusanen M, Kivipelto M, Quesenberry CP Jr, Zhou J, Whitmer RA, (2011) Heavy smoking in midlife and long-term risk of Alzheimer disease and vascular dementia. Arch Intern Med 171: 333-339.
10. Yaffe K, (2007) Metabolic syndrome and cognitive decline. Curr Alzheimer Res 4: 123-126.
11. Solomon A, Kivipelto M, Wolozin B, Zhou J, Whitmer RA, (2009) Midlife serum cholesterol and increased risk of Alzheimer's and vascular dementia three decades later. Dement Geriatr Cogn Disord 28: 75-80.
12. Doody RS, (2003) Current treatments for Alzheimer's disease: cholinesterase inhibitors. J Clin Psychiatry 64Suppl 9: 11-17.
13. Morris MC, Evans DA, Bienias JL, Tangney CC, Bennett DA, et al. (2003) Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Arch Neurol 60: 940-946.
14. Kalmijn S, Launer LJ, Ott A, Witteman JC, Hofman A, et al. (1997) Dietary fat intake and the risk of incident dementia in the Rotterdam Study. Ann Neurol 42: 776-782.
15. Barberger-Gateau P, Letenneur L, Deschamps V, Peres K, Dartigues JF, et al. (2002) Fish, meat, and risk of dementia: cohort study. Bmj 325: 932-933.
16. van Gelder BM, Tijhuis M, Kalmijn S, Kromhout D, (2007) Fish consumption, n-3 fatty acids, and subsequent 5-y cognitive decline in elderly men: the Zutphen Elderly Study. Am J Clin Nutr 85: 1142-1147.
17. Lee JH, O'Keefe JH, Lavie CJ, Marchioli R, Harris WS, (2008) Omega-3 fatty acids for cardioprotection. Mayo Clin Proc 83: 324-332.
18. Lavie CJ, Milani RV, Mehra MR, Ventura HO, (2009) Omega-3 polyunsaturated fatty acids and cardiovascular diseases. J Am Coll Cardiol 54: 585-594.
19. Lauritzen L, Hansen HS, Jorgensen MH, Michaelsen KF, (2001) The essentiality of long chain n-3 fatty acids in relation to development and function of the brain and retina. Prog Lipid Res 40: 1-94.
20. Horrocks LA, Farooqui AA, (2004) Docosahexaenoic acid in the diet: its importance in maintenance and restoration of neural membrane function. Prostaglandins Leukot Essent Fatty Acids 70: 361-372.
21. Geleijnse JM, Giltay EJ, Grobbee DE, Donders AR, Kok FJ, (2002) Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials. J Hypertens 20: 1493-1499.
22. Harris WS, (1997) n-3 fatty acids and serum lipoproteins: animal studies. Am J Clin Nutr 65: 1611S-1616S.
23. Sacks FM, Katan M, (2002) Randomized clinical trials on the effects of dietary fat and carbohydrate on plasma lipoproteins and cardiovascular disease. Am J Med 113Suppl 9B: 13S-24S.
24. Leaf A, Kang JX, Xiao YF, Billman GE, (2003) Clinical prevention of sudden cardiac death by n-3 polyunsaturated fatty acids and mechanism of prevention of arrhythmias by n-3 fish oils. Circulation 107: 2646-2652.
25. Harris WS, (1997) n-3 fatty acids and serum lipoproteins: human studies. Am J Clin Nutr 65: 1645S-1654S.
26. Goodfellow J, Bellamy MF, Ramsey MW, Jones CJ, Lewis MJ, (2000) Dietary supplementation with marine omega-3 fatty acids improve systemic large artery endothelial function in subjects with hypercholesterolemia. J Am Coll Cardiol 35: 265-270.
27. Okuda N, Ueshima H, Okayama A, Saitoh S, Nakagawa H, et al. (2005) Relation of long chain n-3 polyunsaturated fatty acid intake to serum high density lipoprotein cholesterol among Japanese men in Japan and Japanese-American men in Hawaii: the INTERLIPID study. Atherosclerosis 178: 371-379.
28. Calder PC, (2001) Polyunsaturated fatty acids, inflammation, and immunity. Lipids 36: 1007-1024.
29. Farkas T, Kitajka K, Fodor E, Csengeri I, Lahdes E, et al. (2000) Docosahexaenoic acid-containing phospholipid molecular species in brains of vertebrates. Proc Natl Acad Sci U S A 97: 6362-6366.
30. Kitajka K, Puskas LG, Zvara A, Hackler L Jr, Barcelo-Coblijn G, et al. (2002) The role of n-3 polyunsaturated fatty acids in brain: modulation of rat brain gene expression by dietary n-3 fatty acids. Proc Natl Acad Sci U S A 99: 2619-2624.
31. Barcelo-Coblijn G, Hogyes E, Kitajka K, Puskas LG, Zvara A, et al. (2003) Modification by docosahexaenoic acid of age-induced alterations in gene expression and molecular composition of rat brain phospholipids. Proc Natl Acad Sci U S A 100: 11321-11326.
32. Bourre JM, Francois M, Youyou A, Dumont O, Piciotti M, et al. (1989) The effects of dietary alpha-linolenic acid on the composition of nerve membranes, enzymatic activity, amplitude of electrophysiological parameters, resistance to poisons and performance of learning tasks in rats. J Nutr 119: 1880-1892.
33. Fontani G, Corradeschi F, Felici A, Alfatti F, Migliorini S, et al. (2005) Cognitive and physiological effects of Omega-3 polyunsaturated fatty acid supplementation in healthy subjects. Eur J Clin Invest 35: 691-699.
34. Joseph JA, Shukitt-Hale B, Denisova NA, Prior RL, Cao G, et al. (1998) Long-term dietary strawberry, spinach, or vitamin E supplementation retards the onset of age-related neuronal signal-transduction and cognitive behavioral deficits. J Neurosci 18: 8047-8055.
35. Guerrero AL, Dorado-Martinez C, Rodriguez A, Pedroza-Rios K, Borgonio-Perez G, et al. (1999) Effects of vitamin E on ozone-induced memory deficits and lipid peroxidation in rats. Neuroreport 10: 1689-1692.
36. Yamada K, Tanaka T, Han D, Senzaki K, Kameyama T, et al. (1999) Protective effects of idebenone and alpha-tocopherol on beta-amyloid-(1-42)-induced learning and memory deficits in rats: implication of oxidative stress in beta-amyloid-induced neurotoxicity in vivo. Eur J Neurosci 11: 83-90.
37. Fujii A, Matsumoto H, Yamamoto H, (1996) Effect of vitamin B complex on neurotransmission and neurite outgrowth. Gen Pharmacol 27: 995-1000.
38. Shrivastava R, Vincent B, Gobron S, Cucuat N, John GW, (2005) Evidence for growth-promoting effects of omega n- 3 fatty acids alone and in combination with a specific vitamin and mineral complex in rat neuroblastoma cells. Nutr Neurosci 8: 317-321.
39. Chiu CC, Su KP, Cheng TC, Liu HC, Chang CJ, et al. (2008) The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: a preliminary randomized double-blind placebo-controlled study. Prog Neuropsychopharmacol Biol Psychiatry 32: 1538-1544.
40. Malouf M, Grimley EJ, Areosa SA (2003) Folic acid with or without vitamin B12 for cognition and dementia. Cochrane Database Syst Rev: CD004514.
41. Malouf R, Areosa Sastre A (2003) Vitamin B12 for cognition. Cochrane Database Syst Rev: CD004326.
42. Malouf R, Grimley Evans J (2003) The effect of vitamin B6 on cognition. Cochrane Database Syst Rev: CD004393.
43. von Arnim CA, Gola U, Biesalski HK, (2010) More than the sum of its parts? Nutrition in Alzheimer's disease. Nutrition 26: 694-700.
44. Holguin S, Huang Y, Liu J, Wurtman R, (2008) Chronic administration of DHA and UMP improves the impaired memory of environmentally impoverished rats. Behav Brain Res 191: 11-16.
45. Holguin S, Martinez J, Chow C, Wurtman R, (2008) Dietary uridine enhances the improvement in learning and memory produced by administering DHA to gerbils. Faseb J 22: 3938-3946.
46. Kavanagh T, Lonergan PE, Lynch MA, (2004) Eicosapentaenoic acid and gamma-linolenic acid increase hippocampal concentrations of IL-4 and IL-10 and abrogate lipopolysaccharide-induced inhibition of long-term potentiation. Prostaglandins Leukot Essent Fatty Acids 70: 391-397.
47. Broersen LM, Kuipers AA, Balvers M, van Wijk N, Savelkoul PJ, et al. (2013) A specific multi-nutrient diet reduces Alzheimer-like pathology in young adult AbetaPPswe/PS1dE9 mice. J Alzheimers Dis 33: 177-190.
48. Savelkoul PJ, Janickova H, Kuipers AA, Hageman RJ, Kamphuis PJ, et al. (2012) A specific multi-nutrient formulation enhances M1 muscarinic acetylcholine receptor responses in vitro. J Neurochem 120: 631-640.
49. Wurtman RJ, (2008) Synapse formation and cognitive brain development: effect of docosahexaenoic acid and other dietary constituents. Metabolism 57Suppl 2: S6-10.
50. Wurtman RJ, Ulus IH, Cansev M, Watkins CJ, Wang L, et al. (2006) Synaptic proteins and phospholipids are increased in gerbil brain by administering uridine plus docosahexaenoic acid orally. Brain Res 1088: 83-92.
51. Scheltens P, Kamphuis PJ, Verhey FR, Olde Rikkert MG, Wurtman RJ, et al. (2010) Efficacy of a medical food in mild Alzheimer's disease: A randomized, controlled trial. Alzheimers Dement 6: 1-10 e11.
52. Kamphuis PJ, Verhey FR, Olde Rikkert MG, Twisk JW, Swinkels SH, et al. (2011) Efficacy of a medical food on cognition in Alzheimer's disease: results from secondary analyses of a randomized, controlled trial. J Nutr Health Aging 15: 720-724.
53. Scheltens P, Twisk JW, Blesa R, Scarpini E, von Arnim CA, et al. (2012) Efficacy of Souvenaid in mild Alzheimer's disease: results from a randomized, controlled trial. J Alzheimers Dis 31: 225-236.
54. Jankowsky JL, Slunt HH, Ratovitski T, Jenkins NA, Copeland NG, et al. (2001) Co-expression of multiple transgenes in mouse CNS: a comparison of strategies. Biomol Eng 17: 157-165.
55. Jankowsky JL, Fadale DJ, Anderson J, Xu GM, Gonzales V, et al. (2004) Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum Mol Genet 13: 159-170.
56. Kennedy EP, Weiss SB, (1956) The function of cytidine coenzymes in the biosynthesis of phospholipides. J Biol Chem 222: 193-214.
57. Streijger F, Oerlemans F, Ellenbroek BA, Jost CR, Wieringa B, et al. (2005) Structural and behavioural consequences of double deficiency for creatine kinases BCK and UbCKmit. Behav Brain Res 157: 219-234.
58. Hooijmans CR, Van der Zee CE, Dederen PJ, Brouwer KM, Reijmer YD, et al. (2009) DHA and cholesterol containing diets influence Alzheimer-like pathology, cognition and cerebral vasculature in APPswe/PS1dE9 mice. Neurobiol Dis 33: 482-498.
59. Morris R, (1984) Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 11: 47-60.
60. de Bruin JP, Sanchez-Santed F, Heinsbroek RP, Donker A, Postmes P, (1994) A behavioural analysis of rats with damage to the medial prefrontal cortex using the Morris water maze: evidence for behavioural flexibility, but not for impaired spatial navigation. Brain Res 652: 323-333.
61. Cavassila S, Deval S, Huegen C, van Ormondt D, Graveron-Demilly D, (2001) Cramer-Rao bounds: an evaluation tool for quantitation. NMR Biomed 14: 278-283.
62. Govindaraju V, Young K, Maudsley AA, (2000) Proton NMR chemical shifts and coupling constants for brain metabolites. NMR Biomed 13: 129-153.
63. Francis F, Koulakoff A, Boucher D, Chafey P, Schaar B, et al. (1999) Doublecortin is a developmentally regulated, microtubule-associated protein expressed in migrating and differentiating neurons. Neuron 23: 247-256.
64. Gleeson JG, Lin PT, Flanagan LA, Walsh CA, (1999) Doublecortin is a microtubule-associated protein and is expressed widely by migrating neurons. Neuron 23: 257-271.
65. Franklin KBJ, Paxinos G (1997) The mouse brain in stereotaxic coordinates. San Diego: Academic Press. xxii, [ca. 187 p.) p.
66. Thelen KM, Rentsch KM, Gutteck U, Heverin M, Olin M, et al. (2006) Brain cholesterol synthesis in mice is affected by high dose of simvastatin but not of pravastatin. J Pharmacol Exp Ther 316: 1146-1152.
67. Lutjohann D, Brzezinka A, Barth E, Abramowski D, Staufenbiel M, et al. (2002) Profile of cholesterol-related sterols in aged amyloid precursor protein transgenic mouse brain. J Lipid Res 43: 1078-1085.
68. Lutjohann D, Stroick M, Bertsch T, Kuhl S, Lindenthal B, et al. (2004) High doses of simvastatin, pravastatin, and cholesterol reduce brain cholesterol synthesis in guinea pigs. Steroids 69: 431-438.
69. Schmittgen TD, Livak KJ, (2008) Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3: 1101-1108.
70. Simon P, Dupuis R, Costentin J, (1994) Thigmotaxis as an index of anxiety in mice. Influence of dopaminergic transmissions. Behav Brain Res 61: 59-64.
71. Ackl N, Ising M, Schreiber YA, Atiya M, Sonntag A, et al. (2005) Hippocampal metabolic abnormalities in mild cognitive impairment and Alzheimer's disease. Neurosci Lett 384: 23-28.
72. Frederick BD, Lyoo IK, Satlin A, Ahn KH, Kim MJ, et al. (2004) In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry 28: 1313-1322.
73. Bjorkhem I, (2006) Crossing the barrier: oxysterols as cholesterol transporters and metabolic modulators in the brain. J Intern Med 260: 493-508.
74. Heverin M, Bogdanovic N, Lutjohann D, Bayer T, Pikuleva I, et al. (2004) Changes in the levels of cerebral and extracerebral sterols in the brain of patients with Alzheimer's disease. J Lipid Res 45: 186-193.
75. Heverin M, Meaney S, Lutjohann D, Diczfalusy U, Wahren J, et al. (2005) Crossing the barrier: net flux of 27-hydroxycholesterol into the human brain. J Lipid Res 46: 1047-1052.
76. Jansen D, Zerbi V, Janssen CI, Dederen PJ, Mutsaers MP, et al. (2013) A Longitudinal Study of Cognition, Proton MR Spectroscopy and Synaptic and Neuronal Pathology in Aging Wild-type and AbetaPPswe-PS1dE9 Mice. PLoS One 8: e63643.
77. Lalonde R, Fukuchi K, Strazielle C, (2012) APP transgenic mice for modelling behavioural and psychological symptoms of dementia (BPSD). Neurosci Biobehav Rev 36: 1357-1375.
78. Lalonde R, Kim HD, Maxwell JA, Fukuchi K, (2005) Exploratory activity and spatial learning in 12-month-old APP(695)SWE/co+PS1/DeltaE9 mice with amyloid plaques. Neurosci Lett 390: 87-92.
79. Lalonde R, Kim HD, Fukuchi K, (2004) Exploratory activity, anxiety, and motor coordination in bigenic APPswe + PS1/DeltaE9 mice. Neurosci Lett 369: 156-161.
80. Puolivali J, Wang J, Heikkinen T, Heikkila M, Tapiola T, et al. (2002) Hippocampal A beta 42 levels correlate with spatial memory deficit in APP and PS1 double transgenic mice. Neurobiol Dis 9: 339-347.
81. Pugh PL, Richardson JC, Bate ST, Upton N, Sunter D, (2007) Non-cognitive behaviours in an APP/PS1 transgenic model of Alzheimer's disease. Behav Brain Res 178: 18-28.
82. Grossberg GT, (2003) Diagnosis and treatment of Alzheimer's disease. J Clin Psychiatry 64Suppl 9: 3-6.
83. Ferretti L, McCurry SM, Logsdon R, Gibbons L, Teri L, (2001) Anxiety and Alzheimer's disease. J Geriatr Psychiatry Neurol 14: 52-58.
84. Teri L, Ferretti LE, Gibbons LE, Logsdon RG, McCurry SM, et al. (1999) Anxiety of Alzheimer's disease: prevalence, and comorbidity. J Gerontol A Biol Sci Med Sci 54: M348-352.
85. Bhatia HS, Agrawal R, Sharma S, Huo YX, Ying Z, et al. (2011) Omega-3 fatty acid deficiency during brain maturation reduces neuronal and behavioral plasticity in adulthood. PLoS One 6: e28451.
86. Takeuchi T, Iwanaga M, Harada E, (2003) Possible regulatory mechanism of DHA-induced anti-stress reaction in rats. Brain Res 964: 136-143.
87. Naliwaiko K, Araujo RL, da Fonseca RV, Castilho JC, Andreatini R, et al. (2004) Effects of fish oil on the central nervous system: a new potential antidepressant? Nutr Neurosci 7: 91-99.
88. Carrie I, Smirnova M, Clement M, De JD, Frances H, et al. (2002) Docosahexaenoic acid-rich phospholipid supplementation: effect on behavior, learning ability, and retinal function in control and n-3 polyunsaturated fatty acid deficient old mice. Nutr Neurosci 5: 43-52.
89. Fedorova I, Salem N Jr, (2006) Omega-3 fatty acids and rodent behavior. Prostaglandins Leukot Essent Fatty Acids 75: 271-289.
90. Freund-Levi Y, Basun H, Cederholm T, Faxen-Irving G, Garlind A, et al. (2008) Omega-3 supplementation in mild to moderate Alzheimer's disease: effects on neuropsychiatric symptoms. Int J Geriatr Psychiatry 23: 161-169.
91. Schipper P, Kiliaan AJ, Homberg JR, (2011) A mixed polyunsaturated fatty acid diet normalizes hippocampal neurogenesis and reduces anxiety in serotonin transporter knockout rats. Behav Pharmacol 22: 324-334.
92. Jansen D, Zerbi V, Janssen CI, van Rooij D, Zinnhardt B, et al. (2013) Impact of a multi-nutrient diet on cognition, brain metabolism, hemodynamics, and plasticity in apoE4 carrier and apoE knockout mice. Brain Struct Funct. doi:10.1007/s00429-013-0606-7.
93. Garthe A, Behr J, Kempermann G, (2009) Adult-generated hippocampal neurons allow the flexible use of spatially precise learning strategies. PLoS One 4: e5464.
94. Brody DL, Holtzman DM, (2006) Morris water maze search strategy analysis in PDAPP mice before and after experimental traumatic brain injury. Exp Neurol 197: 330-340.
95. O′Leary TP, Brown RE, (2009) Visuo-spatial learning and memory deficits on the Barnes maze in the 16-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease. Behav Brain Res 201: 120-127.
96. Lovasic L, Bauschke H, Janus C, (2005) Working memory impairment in a transgenic amyloid precursor protein TgCRND8 mouse model of Alzheimer's disease. Genes Brain Behav 4: 197-208.
97. Janus C, (2004) Search strategies used by APP transgenic mice during navigation in the Morris water maze. Learn Mem 11: 337-346.
98. Taniuchi N, Niidome T, Goto Y, Akaike A, Kihara T, et al. (2007) Decreased proliferation of hippocampal progenitor cells in APPswe/PS1dE9 transgenic mice. Neuroreport 18: 1801-1805.
99. Niidome T, Taniuchi N, Akaike A, Kihara T, Sugimoto H, (2008) Differential regulation of neurogenesis in two neurogenic regions of APPswe/PS1dE9 transgenic mice. Neuroreport 19: 1361-1364.
100. Hamilton A, Holscher C, (2012) The effect of ageing on neurogenesis and oxidative stress in the APP(swe)/PS1(deltaE9) mouse model of Alzheimer's disease. Brain Res 1449: 83-93.
101. Enciu AM, Nicolescu MI, Manole CG, Muresanu DF, Popescu LM, et al. (2011) Neuroregeneration in neurodegenerative disorders. BMC Neurol 11: 75.
102. Lazarov O, Marr RA, (2010) Neurogenesis and Alzheimer's disease: at the crossroads. Exp Neurol 223: 267-281.
103. Chen G, Chen KS, Knox J, Inglis J, Bernard A, et al. (2000) A learning deficit related to age and beta-amyloid plaques in a mouse model of Alzheimer's disease. Nature 408: 975-979.
104. Locascio JJ, Growdon JH, Corkin S, (1995) Cognitive test performance in detecting, staging, and tracking Alzheimer's disease. Arch Neurol 52: 1087-1099.
105. Small BJ, Mobly JL, Laukka EJ, Jones S, Backman L (2003) Cognitive deficits in preclinical Alzheimer's disease. Acta Neurol Scand Suppl 179: 29-33.
106. Welsh K, Butters N, Hughes J, Mohs R, Heyman A, (1991) Detection of abnormal memory decline in mild cases of Alzheimer's disease using CERAD neuropsychological measures. Arch Neurol 48: 278-281.
107. Vorhees CV, Williams MT, (2006) Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat Protoc 1: 848-858.
108. Van Dam D, Lenders G, De Deyn PP, (2006) Effect of Morris water maze diameter on visual-spatial learning in different mouse strains. Neurobiol Learn Mem 85: 164-172.
109. Tanabe Y, Hashimoto M, Sugioka K, Maruyama M, Fujii Y, et al. (2004) Improvement of spatial cognition with dietary docosahexaenoic acid is associated with an increase in Fos expression in rat CA1 hippocampus. Clin Exp Pharmacol Physiol 31: 700-703.
110. Song C, Horrobin D, (2004) Omega-3 fatty acid ethyl-eicosapentaenoate, but not soybean oil, attenuates memory impairment induced by central IL-1beta administration. J Lipid Res 45: 1112-1121.
111. De Bruin NM, Kiliaan AJ, De Wilde MC, Broersen LM, (2003) Combined uridine and choline administration improves cognitive deficits in spontaneously hypertensive rats. Neurobiol Learn Mem 80: 63-79.
112. Teather LA, Wurtman RJ, (2003) Dietary cytidine (5′)-diphosphocholine supplementation protects against development of memory deficits in aging rats. Prog Neuropsychopharmacol Biol Psychiatry 27: 711-717.
113. Conte V, Uryu K, Fujimoto S, Yao Y, Rokach J, et al. (2004) Vitamin E reduces amyloidosis and improves cognitive function in Tg2576 mice following repetitive concussive brain injury. J Neurochem 90: 758-764.
114. Green KN, Steffan JS, Martinez-Coria H, Sun X, Schreiber SS, et al. (2008) Nicotinamide restores cognition in Alzheimer's disease transgenic mice via a mechanism involving sirtuin inhibition and selective reduction of Thr231-phosphotau. J Neurosci 28: 11500-11510.
115. Figueiredo CP, Bicca MA, Latini A, Prediger RD, Medeiros R, et al. (2011) Folic acid plus alpha-tocopherol mitigates amyloid-beta-induced neurotoxicity through modulation of mitochondrial complexes activity. J Alzheimers Dis 24: 61-75.
116. Oksman M, Iivonen H, Hogyes E, Amtul Z, Penke B, et al. (2006) Impact of different saturated fatty acid, polyunsaturated fatty acid and cholesterol containing diets on beta-amyloid accumulation in APP/PS1 transgenic mice. Neurobiol Dis 23: 563-572.
117. Arendash GW, Jensen MT, Salem N Jr, Hussein N, Cracchiolo J, et al. (2007) A diet high in omega-3 fatty acids does not improve or protect cognitive performance in Alzheimer's transgenic mice. Neuroscience 149: 286-302.
118. Farina N, Isaac MG, Clark AR, Rusted J, Tabet N, (2012) Vitamin E for Alzheimer's dementia and mild cognitive impairment. Cochrane Database Syst Rev 11: CD002854.
119. van de Rest O, Geleijnse JM, Kok FJ, van Staveren WA, Dullemeijer C, et al. (2008) Effect of fish oil on cognitive performance in older subjects: a randomized, controlled trial. Neurology 71: 430-438.
120. Rogers PJ, Appleton KM, Kessler D, Peters TJ, Gunnell D, et al. (2008) No effect of n-3 long-chain polyunsaturated fatty acid (EPA and DHA) supplementation on depressed mood and cognitive function: a randomised controlled trial. Br J Nutr 99: 421-431.
121. Dangour AD, Allen E, Elbourne D, Fasey N, Fletcher AE, et al. (2010) Effect of 2-y n-3 long-chain polyunsaturated fatty acid supplementation on cognitive function in older people: a randomized, double-blind, controlled trial. Am J Clin Nutr 91: 1725-1732.
122. Kotani S, Sakaguchi E, Warashina S, Matsukawa N, Ishikura Y, et al. (2006) Dietary supplementation of arachidonic and docosahexaenoic acids improves cognitive dysfunction. Neurosci Res 56: 159-164.
123. Freund-Levi Y, Eriksdotter-Jonhagen M, Cederholm T, Basun H, Faxen-Irving G, et al. (2006) Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial. Arch Neurol 63: 1402-1408.
124. Wiesmann M, Jansen D, Zerbi V, Broersen LM, Garthe A, et al. (2013) Improved Spatial Learning Strategy and Memory in Aged Alzheimer AbetaPPswe/PS1dE9 Mice on a Multi-Nutrient Diet. J Alzheimers Dis. doi:10.3223/JAD-130179.
125. Schuff N, Amend D, Ezekiel F, Steinman SK, Tanabe J, et al. (1997) Changes of hippocampal N-acetyl aspartate and volume in Alzheimer's disease. A proton MR spectroscopic imaging and MRI study. Neurology 49: 1513-1521.
126. Griffith HR, den Hollander JA, Okonkwo OC, O'Brien T, Watts RL, et al. (2008) Brain metabolism differs in Alzheimer's disease and Parkinson's disease dementia. Alzheimers Dement 4: 421-427.
127. Kantarci K, (2007) 1H magnetic resonance spectroscopy in dementia. Br J Radiol 80 Spec No 2: S146-152.
128. Watanabe T, Shiino A, Akiguchi I, (2012) Hippocampal metabolites and memory performances in patients with amnestic mild cognitive impairment and Alzheimer's disease. Neurobiol Learn Mem 97: 289-293.
129. Dedeoglu A, Choi JK, Cormier K, Kowall NW, Jenkins BG, (2004) Magnetic resonance spectroscopic analysis of Alzheimer's disease mouse brain that express mutant human APP shows altered neurochemical profile. Brain Res 1012: 60-65.
130. Marjanska M, Curran GL, Wengenack TM, Henry PG, Bliss RL, et al. (2005) Monitoring disease progression in transgenic mouse models of Alzheimer's disease with proton magnetic resonance spectroscopy. Proc Natl Acad Sci U S A 102: 11906-11910.
131. Oberg J, Spenger C, Wang FH, Andersson A, Westman E, et al. (2008) Age related changes in brain metabolites observed by 1H MRS in APP/PS1 mice. Neurobiol Aging 29: 1423-1433.
132. Mlynarik V, Cacquevel M, Sun-Reimer L, Janssens S, Cudalbu C, et al. (2012) Proton and phosphorus magnetic resonance spectroscopy of a mouse model of Alzheimer's disease. J Alzheimers Dis 31Suppl 3: S87-99.
133. Xu W, Zhan Y, Huang W, Wang X, Zhang S, et al. (2010) Reduction of hippocampal N-acetyl aspartate level in aged APP(Swe)/PS1(dE9) transgenic mice is associated with degeneration of CA3 pyramidal neurons. J Neurosci Res 88: 3155-3160.
134. Moffett JR, Ross B, Arun P, Madhavarao CN, Namboodiri AM, (2007) N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology. Prog Neurobiol 81: 89-131.
135. Block W, Traber F, Flacke S, Jessen F, Pohl C, et al. (2002) In-vivo proton MR-spectroscopy of the human brain: assessment of N-acetylaspartate (NAA) reduction as a marker for neurodegeneration. Amino Acids 23: 317-323.
136. Choi IY, Lee SP, Guilfoyle DN, Helpern JA, (2003) In vivo NMR studies of neurodegenerative diseases in transgenic and rodent models. Neurochem Res 28: 987-1001.
137. von Kienlin M, Kunnecke B, Metzger F, Steiner G, Richards JG, et al. (2005) Altered metabolic profile in the frontal cortex of PS2APP transgenic mice, monitored throughout their life span. Neurobiol Dis 18: 32-39.
138. Chen SQ, Cai Q, Shen YY, Wang PJ, Teng GJ, et al. (2012) Age-related changes in brain metabolites and cognitive function in APP/PS1 transgenic mice. Behav Brain Res 235: 1-6.
139. Chen SQ, Wang PJ, Ten GJ, Zhan W, Li MH, et al. (2009) Role of myo-inositol by magnetic resonance spectroscopy in early diagnosis of Alzheimer's disease in APP/PS1 transgenic mice. Dement Geriatr Cogn Disord 28: 558-566.
140. Pfefferbaum A, Adalsteinsson E, Spielman D, Sullivan EV, Lim KO, (1999) In vivo spectroscopic quantification of the N-acetyl moiety, creatine, and choline from large volumes of brain gray and white matter: effects of normal aging. Magn Reson Med 41: 276-284.
141. Kantarci K, Petersen RC, Boeve BF, Knopman DS, Tang-Wai DF, et al. (2004) 1H MR spectroscopy in common dementias. Neurology 63: 1393-1398.
142. Huang W, Alexander GE, Chang L, Shetty HU, Krasuski JS, et al. (2001) Brain metabolite concentration and dementia severity in Alzheimer's disease: a (1)H MRS study. Neurology 57: 626-632.
143. Rose SE, de Zubicaray GI, Wang D, Galloway GJ, Chalk JB, et al. (1999) A 1H MRS study of probable Alzheimer's disease and normal aging: implications for longitudinal monitoring of dementia progression. Magn Reson Imaging 17: 291-299.
144. Meyerhoff DJ, MacKay S, Constans JM, Norman D, Van Dyke C, et al. (1994) Axonal injury and membrane alterations in Alzheimer's disease suggested by in vivo proton magnetic resonance spectroscopic imaging. Ann Neurol 36: 40-47.
145. Ginsberg L, Atack JR, Rapoport SI, Gershfeld NL, (1993) Regional specificity of membrane instability in Alzheimer's disease brain. Brain Res 615: 355-357.
146. MacKay S, Meyerhoff DJ, Constans JM, Norman D, Fein G, et al. (1996) Regional gray and white matter metabolite differences in subjects with AD, with subcortical ischemic vascular dementia, and elderly controls with 1H magnetic resonance spectroscopic imaging. Arch Neurol 53: 167-174.
147. Wurtman RJ, Blusztajn JK, Maire JC, (1985) "Autocannibalism" of choline-containing membrane phospholipids in the pathogenesis of Alzheimer's disease-A hypothesis. Neurochem Int 7: 369-372.
148. Demars M, Hu YS, Gadadhar A, Lazarov O, (2010) Impaired neurogenesis is an early event in the etiology of familial Alzheimer's disease in transgenic mice. J Neurosci Res 88: 2103-2117.
149. Boekhoorn K, Joels M, Lucassen PJ, (2006) Increased proliferation reflects glial and vascular-associated changes, but not neurogenesis in the presenile Alzheimer hippocampus. Neurobiol Dis 24: 1-14.
150. Lazarov O, Mattson MP, Peterson DA, Pimplikar SW, van Praag H, (2010) When neurogenesis encounters aging and disease. Trends Neurosci 33: 569-579.
151. Dyall SC, Michael GJ, Michael-Titus AT, (2010) Omega-3 fatty acids reverse age-related decreases in nuclear receptors and increase neurogenesis in old rats. J Neurosci Res 88: 2091-2102.
152. Kawakita E, Hashimoto M, Shido O, (2006) Docosahexaenoic acid promotes neurogenesis in vitro and in vivo. Neuroscience 139: 991-997.
153. Zhang X, Huang G, Liu H, Chang H, Wilson JX, (2012) Folic acid enhances Notch signaling, hippocampal neurogenesis, and cognitive function in a rat model of cerebral ischemia. Nutr Neurosci 15: 55-61.
154. Das UN, (2008) Folic acid and polyunsaturated fatty acids improve cognitive function and prevent depression, dementia, and Alzheimer's disease-but how and why? Prostaglandins Leukot Essent Fatty Acids 78: 11-19.
155. Cuppini R, Ciaroni S, Cecchini T, Ambrogini P, Ferri P, et al. (2002) Tocopherols enhance neurogenesis in dentate gyrus of adult rats. Int J Vitam Nutr Res 72: 170-176.
156. Bonnet E, Touyarot K, Alfos S, Pallet V, Higueret P, et al. (2008) Retinoic acid restores adult hippocampal neurogenesis and reverses spatial memory deficit in vitamin A deprived rats. PLoS One 3: e3487.
157. Higgins GA, Olschowka JA, (1991) Induction of interleukin-1 beta mRNA in adult rat brain. Brain Res Mol Brain Res 9: 143-148.
158. Eriksson C, Van Dam AM, Lucassen PJ, Bol JG, Winblad B, et al. (1999) Immunohistochemical localization of interleukin-1beta, interleukin-1 receptor antagonist and interleukin-1beta converting enzyme/caspase-1 in the rat brain after peripheral administration of kainic acid. Neuroscience 93: 915-930.
159. Vela JM, Molina-Holgado E, Arevalo-Martin A, Almazan G, Guaza C, (2002) Interleukin-1 regulates proliferation and differentiation of oligodendrocyte progenitor cells. Mol Cell Neurosci 20: 489-502.
160. Mrak RE, Griffin WS, (2005) Glia and their cytokines in progression of neurodegeneration. Neurobiol Aging 26: 349-354.
161. Shaftel SS, Kyrkanides S, Olschowka JA, Miller JN, Johnson RE, et al. (2007) Sustained hippocampal IL-1 beta overexpression mediates chronic neuroinflammation and ameliorates Alzheimer plaque pathology. J Clin Invest 117: 1595-1604.
162. Matousek SB, Ghosh S, Shaftel SS, Kyrkanides S, Olschowka JA, et al. (2012) Chronic IL-1beta-mediated neuroinflammation mitigates amyloid pathology in a mouse model of Alzheimer's disease without inducing overt neurodegeneration. J Neuroimmune Pharmacol 7: 156-164.
163. Shaftel SS, Griffin WS, O'Banion MK, (2008) The role of interleukin-1 in neuroinflammation and Alzheimer disease: an evolving perspective. J Neuroinflammation 5: 7.
164. Depino A, Ferrari C, Pott Godoy MC, Tarelli R, Pitossi FJ, (2005) Differential effects of interleukin-1beta on neurotoxicity, cytokine induction and glial reaction in specific brain regions. J Neuroimmunol 168: 96-110.
165. Basu A, Krady JK, Levison SW, (2004) Interleukin-1: a master regulator of neuroinflammation. J Neurosci Res 78: 151-156.
166. Proescholdt MG, Chakravarty S, Foster JA, Foti SB, Briley EM, et al. (2002) Intracerebroventricular but not intravenous interleukin-1beta induces widespread vascular-mediated leukocyte infiltration and immune signal mRNA expression followed by brain-wide glial activation. Neuroscience 112: 731-749.
167. Shaftel SS, Carlson TJ, Olschowka JA, Kyrkanides S, Matousek SB, et al. (2007) Chronic interleukin-1beta expression in mouse brain leads to leukocyte infiltration and neutrophil-independent blood brain barrier permeability without overt neurodegeneration. J Neurosci 27: 9301-9309.
168. Song C, Manku MS, Horrobin DF, (2008) Long-chain polyunsaturated fatty acids modulate interleukin-1beta-induced changes in behavior, monoaminergic neurotransmitters, and brain inflammation in rats. J Nutr 138: 954-963.
169. Juric DM, Carman-Krzan M, (2001) Interleukin-1 beta, but not IL-1 alpha, mediates nerve growth factor secretion from rat astrocytes via type I IL-1 receptor. Int J Dev Neurosci 19: 675-683.
170. Strijbos PJ, Rothwell NJ, (1995) Interleukin-1 beta attenuates excitatory amino acid-induced neurodegeneration in vitro: involvement of nerve growth factor. J Neurosci 15: 3468-3474.
171. Mason JL, Suzuki K, Chaplin DD, Matsushima GK, (2001) Interleukin-1beta promotes repair of the CNS. J Neurosci 21: 7046-7052.
172. Reeves PG, Nielsen FH, Fahey GC Jr, (1993) AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 123: 1939-1951.